Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Dubovsky

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Vaccine|September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionJames F Cummings, Michele D Spring, Robert J Schwenk, et al.
The New England Journal of Medicine|December 15, 2021
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and MexicoLisa M Dunkle, Karen L Kotloff, Cynthia L Gay, et al.
The New England Journal of Medicine|June 30, 2021
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccinePaul T Heath, Eva P Galiza, David N Baxter, et al.
The New England Journal of Medicine|May 5, 2021
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantVivek Shinde, Sutika Bhikha, Zaheer Hoosain, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Vaccine|September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionJames F Cummings, Michele D Spring, Robert J Schwenk, et al.
The New England Journal of Medicine|December 15, 2021
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and MexicoLisa M Dunkle, Karen L Kotloff, Cynthia L Gay, et al.
The New England Journal of Medicine|June 30, 2021
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccinePaul T Heath, Eva P Galiza, David N Baxter, et al.
The New England Journal of Medicine|May 5, 2021
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantVivek Shinde, Sutika Bhikha, Zaheer Hoosain, et al.
Pageof 6